Page last updated: 2024-10-24

verapamil and Adenomatosis, Familial Endocrine

verapamil has been researched along with Adenomatosis, Familial Endocrine in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Villani, A1
Primieri, P1
De Cosmo, G1

Other Studies

1 other study available for verapamil and Adenomatosis, Familial Endocrine

ArticleYear
Cardiomyopathy in phaeochromocytoma: a case report.
    European journal of anaesthesiology, 1989, Volume: 6, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Anesthesia, Inhalation; Cardiomyopathies; Humans; Male; Multiple End

1989